- Home
- ICAD vs DXR Comparison
ICAD vs DXR Comparison
Compare ICAD & DXR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ICAD
- DXR
- Stock Information
- Founded
- ICAD 1984
- DXR 1970
- Country
- ICAD United States
- DXR United States
- Employees
- ICAD N/A
- DXR N/A
- Industry
- ICAD Medical/Dental Instruments
- DXR Medical/Dental Instruments
- Sector
- ICAD Health Care
- DXR Health Care
- Exchange
- ICAD Nasdaq
- DXR Nasdaq
- Market Cap
- ICAD 40.8M
- DXR 42.6M
- IPO Year
- ICAD 1986
- DXR N/A
- Fundamental
- Price
- ICAD $1.51
- DXR $8.79
- Analyst Decision
- ICAD
- DXR
- Analyst Count
- ICAD 0
- DXR 0
- Target Price
- ICAD N/A
- DXR N/A
- AVG Volume (30 Days)
- ICAD 221.3K
- DXR 7.1K
- Earning Date
- ICAD 08-13-2024
- DXR 01-01-0001
- Dividend Yield
- ICAD N/A
- DXR N/A
- EPS Growth
- ICAD N/A
- DXR N/A
- EPS
- ICAD N/A
- DXR 0.35
- Revenue
- ICAD $18,795,000.00
- DXR $154,205.00
- Revenue This Year
- ICAD $13.15
- DXR N/A
- Revenue Next Year
- ICAD $24.28
- DXR N/A
- P/E Ratio
- ICAD N/A
- DXR $24.96
- Revenue Growth
- ICAD 7.40
- DXR N/A
- 52 Week Low
- ICAD $1.18
- DXR $7.11
- 52 Week High
- ICAD $2.65
- DXR $10.04
- Technical
- Relative Strength Index (RSI)
- ICAD 50.80
- DXR 50.03
- Support Level
- ICAD $1.50
- DXR $7.84
- Resistance Level
- ICAD $1.76
- DXR $9.49
- Average True Range (ATR)
- ICAD 0.10
- DXR 0.52
- MACD
- ICAD -0.02
- DXR 0.08
- Stochastic Oscillator
- ICAD 3.33
- DXR 50.26
About ICAD iCAD Inc.
icad Inc is a medical technology company providing cancer detection and therapy solutions. The Company operates in one segment: Detection. The Detection segment include advanced image analysis and workflow solutions that enable healthcare professionals to serve patients by identifying pathologies, comprehensive range of high-performance, Artificial Intelligence and Computer-Aided Detection (CAD) systems and workflow solutions for 2D and 3D mammography, Magnetic Resonance Imaging and Computed Tomography. The company geographically operates in France, Belgium, Italy, Germany, Switzerland and All other.
About DXR Daxor Corporation
Daxor Corp is a medical instrumentation and biotechnology company focused on blood volume measurement. The company develops and markets the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms in a broad range of medical conditions.